4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-23-003988
Options or other derivatives
- Chief Medical Officer acquired 110,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Levisetti Matteo Chief Medical Officer | 2023-01-17 | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…